Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 246

1.

Effect of Mailed Human Papillomavirus Test Kits vs Usual Care Reminders on Cervical Cancer Screening Uptake, Precancer Detection, and Treatment: A Randomized Clinical Trial.

Winer RL, Lin J, Tiro JA, Miglioretti DL, Beatty T, Gao H, Kimbel K, Thayer C, Buist DSM.

JAMA Netw Open. 2019 Nov 1;2(11):e1914729. doi: 10.1001/jamanetworkopen.2019.14729.

PMID:
31693128
2.

Screening mammography outcomes: risk of breast cancer and mortality by comorbidity score and age.

Demb J, Abraham L, Miglioretti DL, Sprague BL, O'Meara ES, Advani S, Henderson LM, Onega T, Buist DSM, Schousboe JT, Walter LC, Kerlikowske K, Braithwaite D.

J Natl Cancer Inst. 2019 Sep 6. pii: djz172. doi: 10.1093/jnci/djz172. [Epub ahead of print]

PMID:
31593591
3.

A Cost-effectiveness Analysis of Multigene Testing for All Patients With Breast Cancer.

Sun L, Brentnall A, Patel S, Buist DSM, Bowles EJA, Evans DGR, Eccles D, Hopper J, Li S, Southey M, Duffy S, Cuzick J, Dos Santos Silva I, Miners A, Sadique Z, Yang L, Legood R, Manchanda R.

JAMA Oncol. 2019 Oct 3. doi: 10.1001/jamaoncol.2019.3323. [Epub ahead of print]

4.

Pathways to breast cancer screening artificial intelligence algorithm validation.

Lee CI, Houssami N, Elmore JG, Buist DSM.

Breast. 2019 Sep 9. pii: S0960-9776(19)30554-5. doi: 10.1016/j.breast.2019.09.005. [Epub ahead of print]

5.

Patterns of Breast Imaging Use Among Women with a Personal History of Breast Cancer.

Henderson LM, Ichikawa L, Buist DSM, Lee JM, Bush M, Johnson D, Onega T, Nekhlyudov L, Kerlikowske K, Miglioretti DL, Sprague BL, Wernli KJ.

J Gen Intern Med. 2019 Oct;34(10):2098-2106. doi: 10.1007/s11606-019-05181-6. Epub 2019 Aug 13.

PMID:
31410813
6.

Improving the promise of embedded pragmatic trials: Surmountable barriers encountered in an evaluation of home-based HPV self-sampling to increase cervical cancer screening in overdue women.

Buist DSM, Tiro JA, Thayer C, Beatty T, Miglioretti DL, Lin J, Winer RL.

Contemp Clin Trials Commun. 2019 Jul 19;15:100413. doi: 10.1016/j.conctc.2019.100413. eCollection 2019 Sep.

7.

Corrigendum to "Rationale and design of the HOME trial: A pragmatic randomized controlled trial of home-based human papillomavirus (HPV) self-sampling for increasing cervical cancer screening uptake and effectiveness in a U.S. healthcare system" [Contemp. Clin. Trials 64 (2018) 77-87].

Winer R, Tiro JA, Miglioretti DL, Thayer C, Beatty T, Lin J, Gao H, Kimbel K, Buist DSM.

Contemp Clin Trials. 2019 Sep;84:105811. doi: 10.1016/j.cct.2019.07.003. Epub 2019 Jul 13. No abstract available.

PMID:
31307906
8.

Strategies to Identify Women at High Risk of Advanced Breast Cancer During Routine Screening for Discussion of Supplemental Imaging.

Kerlikowske K, Sprague BL, Tosteson ANA, Wernli KJ, Rauscher GH, Johnson D, Buist DSM, Onega T, Henderson LM, O'Meara ES, Miglioretti DL.

JAMA Intern Med. 2019 Jul 1. doi: 10.1001/jamainternmed.2019.1758. [Epub ahead of print]

PMID:
31260054
9.

Re: Cancer outcomes in DCIS patients without locoregional treatment.

Habel LA, Buist DSM.

J Natl Cancer Inst. 2019 Jun 14. pii: djz118. doi: 10.1093/jnci/djz118. [Epub ahead of print] No abstract available.

PMID:
31199466
10.

Surveillance Breast MRI and Mammography: Comparison in Women with a Personal History of Breast Cancer.

Wernli KJ, Ichikawa L, Kerlikowske K, Buist DSM, Brandzel SD, Bush M, Johnson D, Henderson LM, Nekhlyudov L, Onega T, Sprague BL, Lee JM, Lehman CD, Miglioretti DL.

Radiology. 2019 Aug;292(2):311-318. doi: 10.1148/radiol.2019182475. Epub 2019 Jun 4.

11.

Collaborating on Data, Science, and Infrastructure: The 20-Year Journey of the Cancer Research Network.

Doria-Rose VP, Greenlee RT, Buist DSM, Miglioretti DL, Corley DA, Brown JS, Clancy HA, Tuzzio L, Moy LM, Hornbrook MC, Brown ML, Ritzwoller DP, Kushi LH, Greene SM.

EGEMS (Wash DC). 2019 Mar 29;7(1):7. doi: 10.5334/egems.273. Review.

12.

Digital Breast Tomosynthesis: Radiologist Learning Curve.

Miglioretti DL, Abraham L, Lee CI, Buist DSM, Herschorn SD, Sprague BL, Henderson LM, Tosteson ANA, Kerlikowske K; Breast Cancer Surveillance Consortium.

Radiology. 2019 Apr;291(1):34-42. doi: 10.1148/radiol.2019182305. Epub 2019 Feb 26.

PMID:
30806595
13.

Trends in BRCA Test Utilization in an Integrated Health System, 2005-2015.

Knerr S, Bowles EJA, Leppig KA, Buist DSM, Gao H, Wernli KJ.

J Natl Cancer Inst. 2019 Feb 8. doi: 10.1093/jnci/djz008. [Epub ahead of print]

PMID:
30753636
14.

Population-Based Assessment of the Association Between Magnetic Resonance Imaging Background Parenchymal Enhancement and Future Primary Breast Cancer Risk.

Arasu VA, Miglioretti DL, Sprague BL, Alsheik NH, Buist DSM, Henderson LM, Herschorn SD, Lee JM, Onega T, Rauscher GH, Wernli KJ, Lehman CD, Kerlikowske K.

J Clin Oncol. 2019 Apr 20;37(12):954-963. doi: 10.1200/JCO.18.00378. Epub 2019 Jan 9.

PMID:
30625040
15.

Understanding Patients' Perspectives and Information Needs Following a Positive Home Human Papillomavirus Self-Sampling Kit Result.

Tiro JA, Betts AC, Kimbel K, Buist DSM, Mao C, Gao H, Shulman L, Malone C, Beatty T, Lin J, Thayer C, Miglioretti DL, Winer RL.

J Womens Health (Larchmt). 2019 Mar;28(3):384-392. doi: 10.1089/jwh.2018.7070. Epub 2018 Nov 27.

PMID:
30481121
16.

Competing Risks for a Diagnosis of Invasive Breast Cancer-Reply.

Brentnall AR, Buist DSM, Cuzick J.

JAMA Oncol. 2019 Jan 1;5(1):111. doi: 10.1001/jamaoncol.2018.5102. No abstract available.

PMID:
30452738
17.

Primary care physician resource use changes associated with feedback reports.

Chang E, Buist DSM, Handley M, Johnson E, Fuller S, Pardee R, Gundersen G, Reid RJ.

Am J Manag Care. 2018 Oct;24(10):455-461.

18.

A qualitative study exploring patient motivations for screening for lung cancer.

Roth JA, Carter-Harris L, Brandzel S, Buist DSM, Wernli KJ.

PLoS One. 2018 Jul 5;13(7):e0196758. doi: 10.1371/journal.pone.0196758. eCollection 2018.

19.

Cumulative Risk Distribution for Interval Invasive Second Breast Cancers After Negative Surveillance Mammography.

Lee JM, Abraham L, Lam DL, Buist DSM, Kerlikowske K, Miglioretti DL, Houssami N, Lehman CD, Henderson LM, Hubbard RA.

J Clin Oncol. 2018 Jul 10;36(20):2070-2077. doi: 10.1200/JCO.2017.76.8267. Epub 2018 May 2.

20.

Long-term Accuracy of Breast Cancer Risk Assessment Combining Classic Risk Factors and Breast Density.

Brentnall AR, Cuzick J, Buist DSM, Bowles EJA.

JAMA Oncol. 2018 Sep 1;4(9):e180174. doi: 10.1001/jamaoncol.2018.0174. Epub 2018 Sep 13.

21.

Preoperative breast MRI and mortality in older women with breast cancer.

Onega T, Zhu W, Weiss JE, Goodrich M, Tosteson ANA, DeMartini W, Virnig BA, Henderson LM, Buist DSM, Wernli KJ, Kerlikowske K, Hubbard RA.

Breast Cancer Res Treat. 2018 Jul;170(1):149-157. doi: 10.1007/s10549-018-4732-z. Epub 2018 Mar 7.

22.

Family History and Breast Cancer Risk Among Older Women in the Breast Cancer Surveillance Consortium Cohort.

Braithwaite D, Miglioretti DL, Zhu W, Demb J, Trentham-Dietz A, Sprague B, Tice JA, Onega T, Henderson LM, Buist DSM, Ziv E, Walter LC, Kerlikowske K; Breast Cancer Surveillance Consortium.

JAMA Intern Med. 2018 Apr 1;178(4):494-501. doi: 10.1001/jamainternmed.2017.8642.

23.

Breast Biopsy Intensity and Findings Following Breast Cancer Screening in Women With and Without a Personal History of Breast Cancer.

Buist DSM, Abraham L, Lee CI, Lee JM, Lehman C, O'Meara ES, Stout NK, Henderson LM, Hill D, Wernli KJ, Haas JS, Tosteson ANA, Kerlikowske K, Onega T; Breast Cancer Surveillance Consortium.

JAMA Intern Med. 2018 Apr 1;178(4):458-468. doi: 10.1001/jamainternmed.2017.8549.

24.

An Electronic Health Record-based Algorithm to Ascertain the Date of Second Breast Cancer Events.

Chubak J, Onega T, Zhu W, Buist DSM, Hubbard RA.

Med Care. 2017 Dec;55(12):e81-e87. doi: 10.1097/MLR.0000000000000352.

25.

Relationship between preoperative breast MRI and surgical treatment of non-metastatic breast cancer.

Onega T, Weiss JE, Goodrich ME, Zhu W, DeMartini WB, Kerlikowske K, Ozanne E, Tosteson ANA, Henderson LM, Buist DSM, Wernli KJ, Herschorn SD, Hotaling E, O'Donoghue C, Hubbard R.

J Surg Oncol. 2017 Dec;116(8):1008-1015. doi: 10.1002/jso.24796. Epub 2017 Nov 11.

26.

Rationale and design of the HOME trial: A pragmatic randomized controlled trial of home-based human papillomavirus (HPV) self-sampling for increasing cervical cancer screening uptake and effectiveness in a U.S. healthcare system.

Winer RL, Tiro JA, Miglioretti DL, Thayer C, Beatty T, Lin J, Gao H, Kimbel K, Buist DSM.

Contemp Clin Trials. 2018 Jan;64:77-87. doi: 10.1016/j.cct.2017.11.004. Epub 2017 Nov 4. Erratum in: Contemp Clin Trials. 2019 Sep;84:105811.

27.

Cancer Screening Reminders: Addressing the Spectrum of Patient Preferences.

Brandzel SD, Bowles EJA, Wieneke A, Bradford SC, Kimbel K, Gao H, Buist DS.

Perm J. 2017;21:17-051. doi: 10.7812/TPP/17-051.

28.

Emerging Trends in Family History of Breast Cancer and Associated Risk.

Shiyanbola OO, Arao RF, Miglioretti DL, Sprague BL, Hampton JM, Stout NK, Kerlikowske K, Braithwaite D, Buist DSM, Egan KM, Newcomb PA, Trentham-Dietz A.

Cancer Epidemiol Biomarkers Prev. 2017 Dec;26(12):1753-1760. doi: 10.1158/1055-9965.EPI-17-0531. Epub 2017 Oct 6.

29.

Artificial intelligence for breast cancer screening: Opportunity or hype?

Houssami N, Lee CI, Buist DSM, Tao D.

Breast. 2017 Dec;36:31-33. doi: 10.1016/j.breast.2017.09.003. Epub 2017 Sep 20.

PMID:
28938172
30.

Breast cancer screening outreach effectiveness: Mammogram-specific reminders vs. comprehensive preventive services birthday letters.

Buist DSM, Gao H, Anderson ML, Onega T, Brandzel S, Rabelhofer MA, Bradford SC, Aiello Bowles EJ.

Prev Med. 2017 Sep;102:49-58. doi: 10.1016/j.ypmed.2017.06.028. Epub 2017 Jun 24.

31.

Performance Benchmarks for Screening Breast MR Imaging in Community Practice.

Lee JM, Ichikawa L, Valencia E, Miglioretti DL, Wernli K, Buist DSM, Kerlikowske K, Henderson LM, Sprague BL, Onega T, Rauscher GH, Lehman CD.

Radiology. 2017 Oct;285(1):44-52. doi: 10.1148/radiol.2017162033. Epub 2017 Jun 5.

32.

Correlation Between Screening Mammography Interpretive Performance on a Test Set and Performance in Clinical Practice.

Miglioretti DL, Ichikawa L, Smith RA, Buist DSM, Carney PA, Geller B, Monsees B, Onega T, Rosenberg R, Sickles EA, Yankaskas BC, Kerlikowske K.

Acad Radiol. 2017 Oct;24(10):1256-1264. doi: 10.1016/j.acra.2017.03.016. Epub 2017 May 24.

33.

Will Machine Learning Tip the Balance in Breast Cancer Screening?

Trister AD, Buist DSM, Lee CI.

JAMA Oncol. 2017 Nov 1;3(11):1463-1464. doi: 10.1001/jamaoncol.2017.0473. No abstract available.

PMID:
28472204
34.

Evidence for Detection Bias by Medication Use in a Cohort Study of Breast Cancer Survivors.

Wirtz HS, Calip GS, Buist DSM, Gralow JR, Barlow WE, Gray S, Boudreau DM.

Am J Epidemiol. 2017 Apr 15;185(8):661-672. doi: 10.1093/aje/kww242.

35.

National Performance Benchmarks for Modern Diagnostic Digital Mammography: Update from the Breast Cancer Surveillance Consortium.

Sprague BL, Arao RF, Miglioretti DL, Henderson LM, Buist DS, Onega T, Rauscher GH, Lee JM, Tosteson AN, Kerlikowske K, Lehman CD; Breast Cancer Surveillance Consortium.

Radiology. 2017 Apr;283(1):59-69. doi: 10.1148/radiol.2017161519. Epub 2017 Feb 28.

36.

Physician Service Attribution Methods for Examining Provision of Low-Value Care.

Chang E, Buist DS, Handley M, Pardee R, Gundersen G, Reid RJ.

EGEMS (Wash DC). 2017 Jan 13;4(1):1276. doi: 10.13063/2327-9214.1276. eCollection 2016.

37.

A qualitative study exploring why individuals opt out of lung cancer screening.

Carter-Harris L, Brandzel S, Wernli KJ, Roth JA, Buist DSM.

Fam Pract. 2017 Apr 1;34(2):239-244. doi: 10.1093/fampra/cmw146.

38.

Family History of Breast Cancer, Breast Density, and Breast Cancer Risk in a U.S. Breast Cancer Screening Population.

Ahern TP, Sprague BL, Bissell MCS, Miglioretti DL, Buist DSM, Braithwaite D, Kerlikowske K.

Cancer Epidemiol Biomarkers Prev. 2017 Jun;26(6):938-944. doi: 10.1158/1055-9965.EPI-16-0801. Epub 2017 Jan 17.

39.

National Performance Benchmarks for Modern Screening Digital Mammography: Update from the Breast Cancer Surveillance Consortium.

Lehman CD, Arao RF, Sprague BL, Lee JM, Buist DS, Kerlikowske K, Henderson LM, Onega T, Tosteson AN, Rauscher GH, Miglioretti DL.

Radiology. 2017 Apr;283(1):49-58. doi: 10.1148/radiol.2016161174. Epub 2016 Dec 5.

40.

Latina and Black/African American Women's Perspectives on Cancer Screening and Cancer Screening Reminders.

Brandzel S, Chang E, Tuzzio L, Campbell C, Coronado N, Bowles EJ, Bradford SC, Buist DS.

J Racial Ethn Health Disparities. 2016 Nov 18. [Epub ahead of print]

41.

Taking action on overuse: Creating the culture for change.

Parchman ML, Henrikson NB, Blasi PR, Buist DS, Penfold R, Austin B, Ganos EH.

Healthc (Amst). 2017 Dec;5(4):199-203. doi: 10.1016/j.hjdsi.2016.10.005. Epub 2016 Nov 10.

42.

Radiologist Agreement for Mammographic Recall by Case Difficulty and Finding Type.

Onega T, Smith M, Miglioretti DL, Carney PA, Geller BA, Kerlikowske K, Buist DS, Rosenberg RD, Smith RA, Sickles EA, Haneuse S, Anderson ML, Yankaskas B.

J Am Coll Radiol. 2016 Nov;13(11S):e72-e79. doi: 10.1016/j.jacr.2016.09.035.

PMID:
27814827
43.

An Automated Method for Identifying Individuals with a Lung Nodule Can Be Feasibly Implemented Across Health Systems.

Farjah F, Halgrim S, Buist DS, Gould MK, Zeliadt SB, Loggers ET, Carrell DS.

EGEMS (Wash DC). 2016 Aug 26;4(1):1254. doi: 10.13063/2327-9214.1254. eCollection 2016.

44.

The Role of Preoperative Magnetic Resonance Imaging in the Assessment and Surgical Treatment of Interval and Screen-Detected Breast Cancer in Older Women.

Goodrich ME, Weiss J, Onega T, Balch SL, Buist DS, Kerlikowske K, Henderson LM, Hubbard RA; Breast Cancer Surveillance Consortium.

Breast J. 2016 Nov;22(6):616-622. doi: 10.1111/tbj.12651. Epub 2016 Aug 23.

45.

Advanced Imaging and Receipt of Guideline Concordant Care in Women with Early Stage Breast Cancer.

Loggers ET, Buist DS, Gold LS, Zeliadt S, Hunter Merrill R, Etzioni R, Ramsey SD, Sullivan SD, Kessler L.

Int J Breast Cancer. 2016;2016:2182985. doi: 10.1155/2016/2182985. Epub 2016 Jul 25.

46.

The effect of referral for genetic counseling on genetic testing and surgical prevention in women at high risk for ovarian cancer: Results from a randomized controlled trial.

Drescher CW, Beatty JD, Resta R, Andersen MR, Watabayashi K, Thorpe J, Hawley S, Purkey H, Chubak J, Hanson N, Buist DSM, Urban N.

Cancer. 2016 Nov 15;122(22):3509-3518. doi: 10.1002/cncr.30190. Epub 2016 Jul 22.

47.

Radiologists' interpretive skills in screening vs. diagnostic mammography: are they related?

Elmore JG, Cook AJ, Bogart A, Carney PA, Geller BM, Taplin SH, Buist DS, Onega T, Lee CI, Miglioretti DL.

Clin Imaging. 2016 Nov - Dec;40(6):1096-1103. doi: 10.1016/j.clinimag.2016.06.014. Epub 2016 Jul 1.

48.

Locoregional treatment of breast cancer in women with and without preoperative magnetic resonance imaging.

Ozanne EM, Weiss JE, Onega T, DeMartini W, Kerlikowske K, Buist DS, Henderson L, Hubbard RA, Goodrich M, Tosteson AN, Virnig BA, O'Donoghue C.

Am J Surg. 2017 Jan;213(1):132-139.e2. doi: 10.1016/j.amjsurg.2016.03.014. Epub 2016 Jun 12.

49.

Breast MRI in the Diagnostic and Preoperative Workup Among Medicare Beneficiaries With Breast Cancer.

Onega T, Weiss JE, Buist DS, Tosteson AN, Henderson LM, Kerlikowske K, Goodrich ME, O'Donoghue C, Wernli KJ, DeMartini WB, Virnig BA, Bennette CS, Hubbard RA.

Med Care. 2016 Jul;54(7):719-24. doi: 10.1097/MLR.0000000000000542.

50.

Aspirin for the Prevention of Cancer Incidence and Mortality: Systematic Evidence Reviews for the U.S. Preventive Services Task Force.

Chubak J, Whitlock EP, Williams SB, Kamineni A, Burda BU, Buist DS, Anderson ML.

Ann Intern Med. 2016 Jun 21;164(12):814-25. doi: 10.7326/M15-2117. Epub 2016 Apr 12. Review.

PMID:
27064482

Supplemental Content

Loading ...
Support Center